Clinical use

HYALOFAST® is clinically used for the treatment of symptomatic or asymptomatic chondral or osteochondral defects of the knee:

  • ICRS grade III and IV;
  • single or multiple;
  • which may be caused by:
    • acute trauma,
    • repeated micro-trauma,
    • instability and/or malalignment (in association with reconstructive and/or corrective surgery),
    • Osteochondritis Dissecans (OCD);
  • localized on: femoral condyles, trochlea, tibial plateau and patella;
  • patients age: 15–55 (but depending on the biological age of the joint);
  • patients BMI<35 (not obesity).

HYALOFAST® use is not suggested in cases of:

  • osteoarthritic conditions;
  • kissing lesions;
  • immune system disorders;
  • neoplastic diseases;
  • metabolic disorders;
  • infections.